ARMI | BioFabUSA was thrilled that IEEE asked ARMI founder, Dean Kamen, to speak as part of the SXSW 2018 “Tech for Humanity Series”. While in Austin, Kamen was given the opportunity to sit down with Chris Morris, a writer and editor from CNBC. During his time with Morris, the two discussed the diverse competencies that are coming together as part of ARMI | BioFabUSA to scale the manufacture of engineered tissues. The article, which was just released by CNBC today, discusses how Kamen plans to jumpstart human organ manufacturing in the United States.
Kamen educated a large crowd in March at SXSW 2018 during his session, which focused on the BioFabUSA program and the opportunity presented by bringing together organizations with competencies in electrical engineering, mechanical engineering, computer science, robotics and automation together with biologists. Click here to listen to Kamen’s talk, “Regenerative Medicine & Human Tissue Manufacturing”, in full!